Unknown

Dataset Information

0

Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants.


ABSTRACT: Solid organ transplantation is the preferred treatment for end-stage organ failure. Although transplant recipients take life-long immunosuppressive drugs, a substantial percentage of them still reject their allografts. Strikingly, barrier organs colonized with microbiota have significantly shorter half-lives than non-barrier transplanted organs, even in immunosuppressed hosts. We previously demonstrated that skin allografts monocolonized with the common human commensal Staphylococcus epidermidis (S.epi) are rejected faster than germ-free (GF) allografts in mice because the presence of S.epi augments the effector alloimmune response locally in the graft. Here, we tested whether host immune responses against graft-resident commensal microbes, including S.epi, can damage colonized grafts independently from the alloresponse. Naive hosts mounted an anticommensal T cell response to colonized, but not GF, syngeneic skin grafts. Whereas naive antigraft commensal T cells modestly damaged colonized syngeneic skin grafts, hosts with prior anticommensal T cell memory mounted a post-transplant immune response against graft-resident commensals that significantly damaged colonized, syngeneic skin grafts. Importantly, allograft recipients harboring this host-versus-commensal immune response resisted immunosuppression. The dual effects of host-versus-commensal and host-versus-allograft responses may partially explain why colonized organs have poorer outcomes than sterile organs in the clinic.

SUBMITTER: Pirozzolo I 

PROVIDER: S-EPMC9435649 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants.

Pirozzolo Isabella I   Sepulveda Martin M   Chen Luqiu L   Wang Ying Y   Lei Yuk Man YM   Li Zhipeng Z   Li Rena R   Sattar Husain H   Theriault Betty B   Belkaid Yasmine Y   Chong Anita S AS   Alegre Maria-Luisa ML  

The Journal of clinical investigation 20220901 17


Solid organ transplantation is the preferred treatment for end-stage organ failure. Although transplant recipients take life-long immunosuppressive drugs, a substantial percentage of them still reject their allografts. Strikingly, barrier organs colonized with microbiota have significantly shorter half-lives than non-barrier transplanted organs, even in immunosuppressed hosts. We previously demonstrated that skin allografts monocolonized with the common human commensal Staphylococcus epidermidis  ...[more]

Similar Datasets

| S-EPMC5490786 | biostudies-literature
| S-EPMC6877588 | biostudies-literature
| S-EPMC2967747 | biostudies-literature
| S-EPMC6347371 | biostudies-literature
| S-EPMC3076856 | biostudies-literature
| S-EPMC11599096 | biostudies-literature
| S-EPMC7137354 | biostudies-literature
| S-EPMC6167008 | biostudies-literature
| S-EPMC6755054 | biostudies-literature
| S-EPMC8096660 | biostudies-literature